by telrheum | Mar 21, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The presentation of RA typically involves symmetric joint pain, stiffness, and swelling, most commonly affecting the hands, wrists, and feet. The stiffness is often worse in the morning or after periods of inactivity, lasting for more than thirty minutes. RA can also...
by telrheum | Mar 18, 2024 | Rheumatic Drugs, Biologic Therapy, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis
Arthritis is a common condition characterized by inflammation of one or more joints, leading to pain, swelling, stiffness, and reduced range of motion. It affects millions of people worldwide and can significantly impact quality of life. There are several types of...
by telrheum | Mar 16, 2024 | Biologic Therapy, Psoriatic Arthritis, Rheumatic Drugs, Spondyloarthritis
Bimekizumab, a novel biologic therapy, is showing promising results in the treatment of psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis (nr-axSpA, M46.80). This medication belongs to a class of drugs known as monoclonal...
by telrheum | Mar 16, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis, Vaccines
The American College of Rheumatology (ACR) has provided guidance on the timing of COVID-19 booster vaccinations for patients undergoing biologic therapy. These recommendations are essential for ensuring that patients with rheumatic diseases, who are often on...
by telrheum | Mar 16, 2024 | Cybersecurity, Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The Cybersecurity Incident at Change Healthcare Change Healthcare, a prominent player in the U.S. insurance claim processing sector, has experienced a cybersecurity breach, leading to significant disruptions in provider and pharmacy operations. This has affected the...